SHARON PAIZ: Open Payments
NPI 1538846415 · MONTCLAIR, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 39 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $712 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $258 |
| Amgen Inc. | 12 | $151 |
| Lilly USA, LLC | 4 | $98 |
| Organon LLC | 2 | $43 |
| PFIZER INC. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Astellas Pharma US Inc | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
Products named: OTEZLA, Wegovy, MOUNJARO, NEXPLANON, PREVNAR 20, AUSTEDO XR, ZEPBOUND, Ozempic.
Industry payments across CA — which companies pay providers there.
